Shadow On Novartis' Ceritinib In India After Patent Revoked

 
• By Anju Ghangurde

A patent on Novartis’ceritinib has been rescinded in India, giving challenger Natco the upper hand, though the Swiss multinational has filed an appeal and hopes to have the patent reinstated.

Gavel_Scales
Novartis' Patent On Ceritinib Revoked In India • Source: Shutterstock

More from India

More from Focus On Asia